Tianjin Zhongxin gets GMP certification for herbal medicinal slices
TIANJIN Zhongxin Pharmaceutical Group said on Monday that the Anhui Medical Products Administration has recently awarded its wholly-owned subsidiary a certificate of good manufacturing practices (drug GMP certification) for its pharmaceutical products.
The subsidiary, Tianjin Darentang (Bozhou) Chinese Herbal Medicinal Slices, develops, manufactures and sells traditional Chinese herbal medicinal slices.
It has also obtained approval for the manufacture of 500 different products, which the company believes can meet market demand, the group said.
"The Drug GMP certification is conducive for the company to expand its market share in the traditional Chinese medicine herbal slices market in China," the group said.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Heineken sells more beer in Q1, sticks to outlook
US seeks 36 months’ jail for Binance founder Zhao
China’s Huawei launches new software brand for intelligent driving
Capital A chief Fernandes defers retirement, renews contract for five years
China’s SenseTime soars 36% after unveiling beefier AI model
PBOC steps up rhetoric against long-end government bond rally